These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 7281695)

  • 1. [Clinical experience with sulprostone (author's transl)].
    Brabec W; Dapunt O; Bichler A
    Wien Klin Wochenschr; 1981 Mar; 93(6):193-7. PubMed ID: 7281695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Priming of the cervix with prostaglandins in the first and second trimester].
    Brabec W
    Wien Klin Wochenschr; 1982 Oct; 94(20):554-8. PubMed ID: 7168176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Termination of normal and pathological pregnancy with Sulprostone.
    Fischer Z; Chwalisz K; Michałkiewicz W
    Acta Chir Hung; 1986; 27(3):151-6. PubMed ID: 3825407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Induction of abortion during the second and third trimester of pregnancy with sulprostone (author's transl)].
    Heinzl S; Winkler C
    Geburtshilfe Frauenheilkd; 1981 Mar; 41(3):231-6. PubMed ID: 7215768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A new therapeutic approach for terminating intact and disturbed pregnancies: three years of experience with the prostaglandin E2-derivative sulprostone (SHB 286) (author's transl)].
    Schmidt-Gollwitzer K; Schüssler B; Elger W; Schmidt-Gollwitzer M
    Geburtshilfe Frauenheilkd; 1979 Aug; 39(8):667-75. PubMed ID: 478268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of a new synthetic prostaglandin (sulprostone) in various obstetrical conditions].
    Melis GB; Fruzzetti F; Paoletti AM; Strigini F; Baisi F; Gargiulo T; Pallotti A; Solla E; Sesselego G; Fioretti P
    Minerva Ginecol; 1982 Mar; 34(3):183-90. PubMed ID: 7045735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Combined pericervical and intramuscular administration of prostaglandin for the termination of pregnancy in the 2d and 3d trimester].
    Grünberger W; Husslein P
    Geburtshilfe Frauenheilkd; 1983 Apr; 43(4):240-4. PubMed ID: 6553545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of abortion with sulprostone, a uteroselective prostaglandin E2 derivative: intramuscular route of application.
    Schmidt-Gollwitzer K; Hoebich D; Hardt W; Schuessler B; Schmidt-Gollwitzer M
    Int J Fertil; 1981; 26(2):86-93. PubMed ID: 6114070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The induction of abortion and the priming of the cervix with prostaglandin F2 alpha and prostaglandin E2 by intra-amniotic, extra-amniotic and intra-cervical application (author's transl)].
    Schmidt W; Widmaier G; Ditz S; Kubli F
    Geburtshilfe Frauenheilkd; 1982 Feb; 42(2):118-22. PubMed ID: 6917804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of sulprostone for induction of preoperative cervical dilation or uterine evacuation: a comparison among the effects of different treatment schedules.
    Fruzzetti F; Melis GB; Strigini F; Vettori C; Ricci C; Fioretti P
    Obstet Gynecol; 1988 Nov; 72(5):704-8. PubMed ID: 3173921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Administration of 15-(S)-15-methyl prostaglandins F2 alpha in intrauterine fetal death, missed abortion and hydatidiform mole (author's transl)].
    Husslein P; Reinold E
    Wien Klin Wochenschr; 1979 Jun; 91(13):458-60. PubMed ID: 463045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [16-Phenoxy-prostaglandin-E2 for inducing abortion in intact and complicated pregnancy].
    Lichtenegger W
    Geburtshilfe Frauenheilkd; 1984 Nov; 44(11):752-7. PubMed ID: 6569011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Preoperative cervical dilatation in abortion during the 1st trimester with sulprostone].
    Schulz BO; Gethmann U; Lehmann F
    Geburtshilfe Frauenheilkd; 1984 Mar; 44(3):185-7. PubMed ID: 6562984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experiences with sulproston for cervical priming in pregnancy termination in the 1st trimester].
    Heinzl S; Winkler C; Allemann F
    Gynakol Rundsch; 1982; 22(4):233-40. PubMed ID: 7160659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extra-amniotic prostaglandin E2 and intravenous oxytocin in termination of mid-trimester pregnancy and the management of missed abortion and hydatiform mole.
    Arshat H
    Med J Malaysia; 1977 Mar; 31(3):220-5. PubMed ID: 904515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cervix ripening and labor induction in therapeutic abortion in the middle and late 2d trimester using intracervical and extra-amniotic prostaglandin gel administration].
    Rath W; Ulbrich R; Kuhn W
    Wien Klin Wochenschr; 1985 May; 97(11):486-93. PubMed ID: 3859953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trials of intramuscular sulprostone for second trimester abortion.
    Intaraprasert S; Sugkraroek P
    J Med Assoc Thai; 1988 Mar; 71 Suppl 1():58-62. PubMed ID: 3047304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of labour with sulprostone after foetal death and in hydatidiform mole.
    Saarikoski S; Selander K; Pystynen P
    Prostaglandins; 1980 Sep; 20(3):481-5. PubMed ID: 7422894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulprostone for preoperative cervical dilatation in primigravidae scheduled for late first trimester termination of pregnancy.
    Jerve F; Fylling P
    Arch Gynecol; 1983; 233(3):199-203. PubMed ID: 6625666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Outpatient termination of pregnancy via intramural single-shot application of the prostaglandin derivative sh b 286 (sulproston) (author's transl)].
    Wiechell H
    Geburtshilfe Frauenheilkd; 1979 May; 39(5):401-3. PubMed ID: 456862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.